Director/PDMR Shareholding

RNS Number:6479R
Phoqus Pharmaceuticals PLC
04 April 2008

                           Phoqus Pharmaceuticals plc

                           Directors' share dealings



West Malling, UK, 4 April 2008: Phoqus Pharmaceuticals plc (AIM: PQS) ("Phoqus"
or the "Company"), the drug development company, announces that on 3 April 2008,
Dr Peter Johnson, Chief Financial Officer of Phoqus, transferred 2,166 ordinary
shares ("Shares") in the Company to an exercising option-holder in his capacity
as nominee shareholder.  Also, 2,912 Shares were transferred on the same date to
a trust in which Dr Johnson is a potential beneficiary.

As previously announced, share options granted by the Company on 3 November 2005
were to be satisfied by the transfer of Shares held by certain institutional
shareholders. In order to facilitate the transfer of Shares to option-holders,
some of the institutional shareholders transferred Shares to Dr Peter Johnson,
Chief Financial Officer, to hold the Shares as their nominee pending exercise of
the share options by the option-holders, after which he would transfer the
relevant Shares to the exercising option-holders.

Following the above transfer of 2,166 Shares to the exercising option-holders on
3 April 2008, 371 Shares are now held by Dr Johnson in his capacity as nominee,
representing less than 0.01 per cent of the issued share capital of the Company.


Separately, on 11 May 2006 a trust in which Dr Johnson is a potential
beneficiary exercised options over Shares that had been granted to it by the
Company on 3 November 2005.  Due to the loss of a share certificate by the
transferring institutional investor and subsequent administrative errors, 2,912
of the Shares were never formally transferred to the trust.  The share
certificate has now been replaced and the Shares were transferred to the trust
on 3 April 2008.



Dr Johnson's beneficial ownership of Phoqus Shares has therefore increased by
2,912 to 297,838 ordinary Shares, or 0.65 per cent of the issued share capital
of the Company.


Enquiries:


Phoqus Pharmaceuticals plc
Suzanne Smith, Company Secretary                        Tel:  01732 870227


Nomura Code Securities Limited
Phil Walker                                            Tel:   020 7776 1200



                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

RDSEAFLLESKPEFE

Phoqus (LSE:PQS)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024